A randomized phase III study of adjuvant chemotherapy in patients with completely resected Non-Small Cell Lung Cancer and low-risk for recurrence: NVALT-8A
Phase of Trial: Phase III
Latest Information Update: 05 Jul 2016
At a glance
- Drugs Gemcitabine (Primary) ; Pemetrexed (Primary) ; Antineoplastics; Cisplatin; Docetaxel; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms NVALT-8A
- 27 Aug 2013 New source identified and integrated (Netherlands Trial Register; NTR1217).
- 01 Oct 2008 New trial record.